Biocryst Pharmaceuticals (BCRX) FCF Margin (2010 - 2026)
Biocryst Pharmaceuticals' (BCRX) quarterly FCF Margin came in at 39.89% in Q1 2026, down 2099.0% YoY from 2.0% in Q1 2025, and down 100.1% on a QoQ basis from 41386.72% in Q4 2025.
Biocryst Pharmaceuticals (BCRX) FCF Margin (2010 - 2026) Analysis & Trends
Biocryst Pharmaceuticals (BCRX) has 17 years of FCF Margin data on file, last reported at 39.89% in Q1 2026.
- Quarterly FCF Margin fell 2099.0% year-over-year to 39.89% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 64.99% (up 7008.0% YoY) and the FY2025 annual result came in at 39.64%, up 5118.0% from the prior year.
- FCF Margin retreated to 39.89% in Q1 2026, from 41386.72% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 41386.72% in Q4 2025 to a low of 156.65% in Q1 2022.
- A 5-year average of 2407.33% and a median of 23.37% in 2023 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2025 — FCF Margin jumped 4139035 bps — and 2026, when it slumped 2099 bps.
- Tracing BCRX's FCF Margin over 5 years: stood at 30.64% in 2022, then soared by 74 bps to 7.82% in 2023, then surged by 54 bps to 3.62% in 2024, then jumped by 1142787 bps to 41386.72% in 2025, then plunged by 100 bps to 39.89% in 2026.
- The last three FCF Margin figures came in at 39.89% (Q1 2026), 41386.72% (Q4 2025), and 25.74% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 7.41% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 21.80% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 14.87% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 26.25% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 8.76% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 13.41% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 17.84% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Biocryst Pharmaceuticals | 2.46 Bn | 2.11 Bn | 214.41 Mn | 47.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 47.81% |
| Mar 31, 2026 | -39.89% |
| Dec 31, 2025 | 41,386.72% |
| Sep 30, 2025 | 25.74% |
| Jun 30, 2025 | 24.63% |
| Mar 31, 2025 | -18.91% |
| Dec 31, 2024 | -3.62% |
| Sep 30, 2024 | 6.66% |
| Jun 30, 2024 | -1.04% |
| Mar 31, 2024 | -58.13% |
| Dec 31, 2023 | -7.82% |
| Sep 30, 2023 | -24.08% |
| Jun 30, 2023 | -23.37% |
| Mar 31, 2023 | -69.31% |
| Dec 31, 2022 | -30.64% |
| Sep 30, 2022 | -43.02% |
| Jun 30, 2022 | -42.73% |
| Mar 31, 2022 | -156.65% |
| Dec 31, 2021 | -71.18% |
| Sep 30, 2021 | -57.67% |